平阳霉素联合地塞米松治疗颌面部血管瘤的效果观察(1)
[摘要]目的 观察平阳霉素联合地塞米松治疗颌面部血管瘤的效果。方法 选取我院2015年1月～2016年9月收治的80例颌面部血管瘤患者，按照治疗方式不同分为观察组和对照组，各40例。对照组实施传统手术治疗，观察组实施平阳霉素联合地塞米松治疗。比较两组的总有效率、住院总耗时、症状消失时间、住院费用。结果 观察组的总有效率为87.50%，高于对照组的60.00%，差异有统计学意义(P<0.05)。观察组的住院总耗时、症状消失时间短于对照组，住院费用少于对照组，差异有统计学意义(P<0.05)。结论 平阳霉素联合地塞米松治疗颌面部血管瘤具有显著的效果。
[关键词]平阳霉素；地塞米松；颌面部血管瘤；效果观察
[中图分类号] R739.81 [文献标识码] A [文章编号] 1674-4721(2017)04(b)-0114-03
Effect observation of Pingyangmycin combined with Dexamethasone in the treatment of maxillofacial hemangioma
XIA Li-xia
Department of Stomatology，the First People′s Hospital of Jingdezhen City in Jiangxi Province，Jingdezhen 333000，China
[Abstract]Objective To observe the effect of Pingyangmycin combined with Dexamethasone in the treatment of maxillofacial hemangioma.Methods 80 patients with maxillofacial hemangioma from January 2015 to September 2016 in our hospital were selected and divided into the observation group and the control group according to different treatment methods，40 patients in each group.The control group was treated with traditional surgical treatment，the observation group was treated with Pingyangmycin combined with Dexamethasone treatment.The total effective rate，hospitalization time，the disappearance time of symptoms，hospital costs in the two groups were compared.Results The total effective rate of the observation group was 87.50%，which was higher than that of the control group (60.00%)，with significant difference (P<0.05).The time of hospitalization，the disappearance time of symptoms in the observation group was shorter than that in the control group，the hospitalization cost in the observation group was less than that in the control group，with significant difference (P<0.05).Conclusion Pingyangmycin combined with Dexamethasone has significant therapeutic effect in the treatment of maxillofacial hemangioma.
[Key words]Pingyangmycin；Dexamethasone；Maxillofacial hemangioma；Effect observation
血管瘤也称为海绵状血管瘤，为常见的先天性血管畸形，病变部位在人体颌面部，口腔颌面部血管瘤为血管先天性良性肿瘤或者血管畸形，为人体软组织常见的肿瘤之一，常见的发病人群为儿童，若未及时进行治疗，易导致病变程度加重，病变范围扩大，呈现进行性缓慢发展[1-2]。目前，臨床中对于该疾病的主要治疗方式为激光治疗、化疗药物局部治疗、硬化剂局部注射、手术治疗、药物治疗，其中药物治疗和传统手术治疗较为常见。本研究旨在探讨平阳霉素联合地塞米松治疗颌面部血管瘤的效果，现报道如下。
1资料与方法
1.1一般资料
选取我院2015年1月～2016年9月收治的80例颌面部血管瘤患者，按照治疗方式不同分为观察组和对照组，各40例。纳入标准：①所有患者均符合颌面部血管瘤诊断标准，患者家属均签署知情同意书，参与本次研究；②患者无地塞米松、平阳霉素等药物禁忌证。排除标准：①不接受手术治疗或者药物治疗患者；②伴有肝、肾、心等器官严重疾病患者。观察组中，男性20例，女性20例；年龄为2～10岁，平均(6.01±1.23)岁。对照组中，男性21例，女性19例；年龄2～11岁，平均(6.35±1.18)岁。两组的一般资料差异比较，差异无统计学意义(P>0.05)，具有可比性。 (夏丽霞)
[关键词]平阳霉素；地塞米松；颌面部血管瘤；效果观察
[中图分类号] R739.81 [文献标识码] A [文章编号] 1674-4721(2017)04(b)-0114-03
Effect observation of Pingyangmycin combined with Dexamethasone in the treatment of maxillofacial hemangioma
XIA Li-xia
Department of Stomatology，the First People′s Hospital of Jingdezhen City in Jiangxi Province，Jingdezhen 333000，China
[Abstract]Objective To observe the effect of Pingyangmycin combined with Dexamethasone in the treatment of maxillofacial hemangioma.Methods 80 patients with maxillofacial hemangioma from January 2015 to September 2016 in our hospital were selected and divided into the observation group and the control group according to different treatment methods，40 patients in each group.The control group was treated with traditional surgical treatment，the observation group was treated with Pingyangmycin combined with Dexamethasone treatment.The total effective rate，hospitalization time，the disappearance time of symptoms，hospital costs in the two groups were compared.Results The total effective rate of the observation group was 87.50%，which was higher than that of the control group (60.00%)，with significant difference (P<0.05).The time of hospitalization，the disappearance time of symptoms in the observation group was shorter than that in the control group，the hospitalization cost in the observation group was less than that in the control group，with significant difference (P<0.05).Conclusion Pingyangmycin combined with Dexamethasone has significant therapeutic effect in the treatment of maxillofacial hemangioma.
[Key words]Pingyangmycin；Dexamethasone；Maxillofacial hemangioma；Effect observation
血管瘤也称为海绵状血管瘤，为常见的先天性血管畸形，病变部位在人体颌面部，口腔颌面部血管瘤为血管先天性良性肿瘤或者血管畸形，为人体软组织常见的肿瘤之一，常见的发病人群为儿童，若未及时进行治疗，易导致病变程度加重，病变范围扩大，呈现进行性缓慢发展[1-2]。目前，臨床中对于该疾病的主要治疗方式为激光治疗、化疗药物局部治疗、硬化剂局部注射、手术治疗、药物治疗，其中药物治疗和传统手术治疗较为常见。本研究旨在探讨平阳霉素联合地塞米松治疗颌面部血管瘤的效果，现报道如下。
1资料与方法
1.1一般资料
选取我院2015年1月～2016年9月收治的80例颌面部血管瘤患者，按照治疗方式不同分为观察组和对照组，各40例。纳入标准：①所有患者均符合颌面部血管瘤诊断标准，患者家属均签署知情同意书，参与本次研究；②患者无地塞米松、平阳霉素等药物禁忌证。排除标准：①不接受手术治疗或者药物治疗患者；②伴有肝、肾、心等器官严重疾病患者。观察组中，男性20例，女性20例；年龄为2～10岁，平均(6.01±1.23)岁。对照组中，男性21例，女性19例；年龄2～11岁，平均(6.35±1.18)岁。两组的一般资料差异比较，差异无统计学意义(P>0.05)，具有可比性。 (夏丽霞)